Table 1.
Characteristics of study participants (N = 316).
| Variable | Number (%) |
|---|---|
| Age | |
| 18–19 | 1 (0.3%) |
| 20–29 | 249 (78.8%) |
| 30–39 | 33 (10.4%) |
| 40–49 | 18 (5.7%) |
| Prefer not to answer | 1 (0.3%) |
| Gender | |
| Female | 149 (47.2%) |
| Male | 158 (50.0%) |
| Other | 2 (0.6%) |
| Prefer not to answer | 5 (1.6%) |
| Race/Ethnicity | |
| White | 182 (57.6%) |
| Black or African American | 12 (3.8%) |
| American Indian or Alaskan Native | 1 (0.3%) |
| Asian | 82 (25.9%) |
| Native Hawaiian or other Pacific islander | 0 (0%) |
| From multiple races | 17 (5.4%) |
| Other | 10 (3.2%) |
| Prefer not to answer | 12 (3.8%) |
| Marital status | |
| Married | 60 (18.9%) |
| Widowed | 0 (0%) |
| Divorced | 5 (1.6%) |
| Separated | 1 (0.3%) |
| Never married | 242 (76.6%) |
| Prefer not to answer | 8 (2.5%) |
| Household income | |
| Below 10 K | 98 (31.0%) |
| 10–50 K | 33 (10.4%) |
| 51–100 K | 55 (17.4%) |
| 101–150 K | 24 (7.6%) |
| 151–200 K | 10 (3.2%) |
| Above 200 K | 18 (5.6%) |
| Prefer not to answer | 77 (24.4%) |
| Campus location | |
| Jonesboro | 101 (32.2%) |
| Old Westbury | 210 (66.2%) |
| Prefer not to answer | 5 (1.6%) |
| Vaccine type | |
| Pfizer-BioNTech | 182/316 (60.5%) |
| Moderna | 103/316 (34.2%) |
| J&J/Janssen | 16/316 (5.3%) |